Tower Research Capital (TRC)’s Cogentix Medical, Inc. CGNT Stock Holding History

Tower Research Capital (TRC)’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,419	Closed	-$36K	–	4431
2018 Q1	$36K	Buy	9,419 +8,405	+829%	+$26.3K	﹤0.01%	1877
2017 Q4	$3K	Buy	+1,014	New	+$2.92K	﹤0.01%	3158
2017 Q3	–	Sell	-17,438	Closed	-$30K	–	4396
2017 Q2	$30K	Buy	17,438 +16,634	+2,069%	+$28.5K	﹤0.01%	1012
2017 Q1	$1K	Buy	+804	New	+$1.59K	﹤0.01%	2930
2016 Q2	–	Sell	-2	Closed	–	–	5366
2016 Q1	$0	Sell	2 -8,098	-100%	-$9.1K	﹤0.01%	5443
2015 Q4	$11K	Buy	+8,100	New	+$11.1K	﹤0.01%	2065

Tower Research Capital (TRC)'s CGNT Position: Q2 2018 in Review

Tower Research Capital (TRC) sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 9,419 shares — an estimated $36K sold.

Tower Research Capital (TRC) first reported a position in CGNT in Q4 2015 and held it in 6 quarters. The position peaked at $36K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

Tower Research Capital (TRC) reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
Tower Research Capital (TRC) sold 9,419 Cogentix Medical, Inc. shares in Q2 2018, an estimated $36K.
Tower Research Capital (TRC) first reported a position in Cogentix Medical, Inc. in Q4 2015 and held it in 6 quarters.
Tower Research Capital (TRC)'s Cogentix Medical, Inc. position peaked at $36K in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.